Publisher： John Wiley & Sons Inc
E-ISSN： 1932-7005|9|12|E302-E307
ISSN： 1932-6254
Source： Journal Of Tissue Engineering And Regenerative Medicine, Vol.9, Iss.12, 2015-12, pp. : E302-E307
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
AbstractHuman embryonic stem cells (hESCs) are pluripotent cells that have the potential to differentiate into the three germ layers and possibly all tissues of the human body. To fulfil the clinical potentials for cell‐based therapy, banks of hESC lines that express different combinations of the major histocompatibility genes should be established, preferably without exposing such cells to animal cells and proteins. In this study, we tested human amniotic fluid mesenchymal stem cells (AFMSCs) as feeder cells to support the growth of hESCs. Our results indicated that mitomycin‐treated AFMSCs were able to support the newly established hESC lines CGLK‐1 and CGLK‐2. The hESC colonies cultured on AFMSCs expressed alkaline phosphatase (ALK‐P), SSEA‐4, TRA‐1‐60, TRA‐1‐81, Oct‐4, Nanog and Sox‐2, which are markers for undifferentiated hESCs. Chromosomal analyses of both hESC lines, CGLK‐1 and CGLK‐2, which were cultured on AFMSC feeders for 22 and 14 passages, respectively, were confirmed to be normal karyotypes (46, XX). The ability of AFMSCs as feeder cells to maintain the undifferentiated growth and pluripotency of hESCs was confirmed by in vivo formation of teratomas derived on AFMSC hESCs in severe combined immune‐compromised mice. The use of AFMSCs for feeder cells to culture hESCs has several advantages, in that AFMSCs are not tumourigenic and can be expanded extensively with a short doubling time. Copyright © 2013 John Wiley & Sons, Ltd.
Related content
Human embryonic stem cell and embryonic germ cell lines
By Thomson J.A.J.A. Odorico J.S.J.S.
Trends in Biotechnology, Vol. 18, Iss. 2, 2000-02 ,pp. :
Access to resources
Recommend
Journal Of Tissue Engineering And Regenerative Medicine, Vol. 12, Iss. 1, 2018-01 ,pp. :